These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28292490)

  • 1. Preference Weighting of Health State Values: What Difference Does It Make, and Why?
    Lamu AN; Gamst-Klaussen T; Olsen JA
    Value Health; 2017 Mar; 20(3):451-457. PubMed ID: 28292490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients.
    Zhao FL; Yue M; Yang H; Wang T; Wu JH; Li SC
    Value Health; 2010 Aug; 13(5):649-56. PubMed ID: 20412540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores.
    McClure NS; Sayah FA; Xie F; Luo N; Johnson JA
    Value Health; 2017 Apr; 20(4):644-650. PubMed ID: 28408007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health utility scores in Alzheimer's disease: differences based on calculation with American and Canadian preference weights.
    Oremus M; Tarride JE; Clayton N; ; Raina P
    Value Health; 2014; 17(1):77-83. PubMed ID: 24438720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating an EQ-5D-5L Value Set for China.
    Luo N; Liu G; Li M; Guan H; Jin X; Rand-Hendriksen K
    Value Health; 2017 Apr; 20(4):662-669. PubMed ID: 28408009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating equivalency between response systems: application of the Rasch model to a 3-level and 5-level EQ-5D.
    Pickard AS; Kohlmann T; Janssen MF; Bonsel G; Rosenbloom S; Cella D
    Med Care; 2007 Sep; 45(9):812-9. PubMed ID: 17712251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the value of social values? The uselessness of assessing health-related quality of life through preference measures.
    Prieto L; Sacristán JA
    BMC Med Res Methodol; 2004 Apr; 4():10. PubMed ID: 15117417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
    Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
    Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis.
    Lillegraven S; Kristiansen IS; Kvien TK
    Ann Rheum Dis; 2010 Oct; 69(10):1762-7. PubMed ID: 20448285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of the EQ-5D in patients with irritable bowel syndrome.
    Bushnell DM; Martin ML; Ricci JF; Bracco A
    Value Health; 2006; 9(2):90-7. PubMed ID: 16626412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of health utility scores calculated using United Kingdom and Canadian preference weights in persons with alzheimer's disease and their caregivers.
    Fang M; Oremus M; Tarride JE; Raina P;
    Health Qual Life Outcomes; 2016 Jul; 14(1):105. PubMed ID: 27431327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the COPD Assessment Test onto EQ-5D.
    Hoyle CK; Tabberer M; Brooks J
    Value Health; 2016 Jun; 19(4):469-77. PubMed ID: 27325339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement.
    Xie F; Li SC; Luo N; Lo NN; Yeo SJ; Yang KY; Fong KY; Thumboo J
    Arthritis Rheum; 2007 Aug; 57(6):1043-9. PubMed ID: 17665466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S; Hockley C
    Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a preference-based index from the National Eye Institute Visual Function Questionnaire-25.
    Rentz AM; Kowalski JW; Walt JG; Hays RD; Brazier JE; Yu R; Lee P; Bressler N; Revicki DA
    JAMA Ophthalmol; 2014 Mar; 132(3):310-8. PubMed ID: 24435696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
    Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
    Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Framing of mobility items: a source of poor agreement between preference-based health-related quality of life instruments in a population of individuals receiving assisted ventilation.
    Hannan LM; Whitehurst DGT; Bryan S; Road JD; McDonald CF; Berlowitz DJ; Howard ME
    Qual Life Res; 2017 Jun; 26(6):1493-1505. PubMed ID: 28255744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer.
    Rowen D; Young T; Brazier J; Gaugris S
    Value Health; 2012 Dec; 15(8):1059-68. PubMed ID: 23244808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises.
    Whitehurst DG; Norman R; Brazier JE; Viney R
    Value Health; 2014 Jul; 17(5):570-7. PubMed ID: 25128050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.